Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 22;10(1):85.
doi: 10.1186/s13613-020-00697-1.

Role of albumin in the preservation of endothelial glycocalyx integrity and the microcirculation: a review

Affiliations
Review

Role of albumin in the preservation of endothelial glycocalyx integrity and the microcirculation: a review

Cesar Aldecoa et al. Ann Intensive Care. .

Abstract

The endothelial glycocalyx comprises a complex layer of membrane-bound proteoglycans, secreted glycosaminoglycans, glycoproteins, glycolipids and bound plasma proteins such as albumin and antithrombin associated with the endothelial surface. The glycocalyx plays an important role in vascular homeostasis, regulating vascular permeability and cell adhesion, and acts as a mechanosensor for hemodynamic shear stresses; it also has antithrombotic and anti-inflammatory functions. Plasma proteins such as albumin are physiologically bound within the glycocalyx, thus contributing to stability of the layer. Albumin is the major determinant of plasma colloid osmotic pressure. In addition, albumin transports sphingosine-1-phosphate which has protective endothelial effects, acts as a free radical scavenger, and has immunomodulatory and anti-inflammatory effects. This review examines the physiological function of the endothelial glycocalyx and the role of human albumin in preserving glycocalyx integrity and the microcirculation.

Keywords: Albumin; Endothelial cell; Glycocalyx; Microcirculation; Sepsis.

PubMed Disclaimer

Conflict of interest statement

Cesar Aldecoa has received payment for lectures and travel expenses from Fresenius, and Octapharma. Juan V Llau has received payment for lectures or participation in educational activities, or travel expenses from Cardinal, CSL-Behring, LFB, Octapharma, Rovi, Sanofi, and Vifor Pharma. Xavier Nuvials has received payment for lectures, and travel expenses from Astellas, Gilead, MSD, and Pfizer. Antonio Artigas has received research grants from Fisher & Paykel, Grifols, and Hill-Rom; has participated in scientific advisory boards for Global Sepsis Alliance, Grifols, and Lilly Foundation; has received payment for lectures or participation in educational activities from Astute, Edwards, and Grifols.

Figures

Fig. 1
Fig. 1
Structure of the endothelial glycocalyx illustrating proteoglycans and glycosaminoglycans. Reproduced with permission from [4]. GPI glycosylphosphatidylinositol
Fig. 2
Fig. 2
Electron micrograph of a cross-sectional image of a coronary endothelial glycocalyx (courtesy of B. van den Berg, Maastricht University). Reproduced with permission from [11]
Fig. 3
Fig. 3
The revised Starling principle. Reproduced with permission from [2]. Jv/A filtered volume per unit area; Lp hydraulic conductance; Pc capillary hydrostatic pressure; Pis interstitial hydrostatic pressure; σ osmotic reflection co-efficient; πp oncotic pressure in the luminal side of endothelial surface layer; πsg oncotic pressure in the subglycocalyx space
Fig. 4
Fig. 4
Pathologies/interventions associated with glycocalyx alterations. Reproduced with permission from [10]. ecSOD extracellular superoxide dismutase; MMP matrix metalloprotease; NO nitric oxide. Sulodexide is a highly purified glycosaminoglycan mixture of low molecular weight heparin plus dermatan sulfate [30]

References

    1. Weinbaum S, Tarbell JM, Damiano ER. The structure and function of the endothelial glycocalyx layer. Annu Rev Biomed Eng. 2007;9:121–167. doi: 10.1146/annurev.bioeng.9.060906.151959. - DOI - PubMed
    1. Alphonsus CS, Rodseth RN. The endothelial glycocalyx: a review of the vascular barrier. Anaesthesia. 2014;69:777–784. doi: 10.1111/anae.12661. - DOI - PubMed
    1. Sieve I, Münster-Kühnel AK, Hilfiker-Kleiner D. Regulation and function of endothelial glycocalyx layer in vascular diseases. Vascul Pharmacol. 2018;100:26–33. doi: 10.1016/j.vph.2017.09.002. - DOI - PubMed
    1. Becker BF, Chappell D, Jacob M. Endothelial glycocalyx and coronary vascular permeability: the fringe benefit. Basic Res Cardiol. 2010;105:687–701. doi: 10.1007/s00395-010-0118-z. - DOI - PubMed
    1. Ushiyama A, Kataoka H, Iijima T. Glycocalyx and its involvement in clinical pathophysiologies. J Intensive Care. 2016;4:59. doi: 10.1186/s40560-016-0182-z. - DOI - PMC - PubMed

Grants and funding

LinkOut - more resources